J Biol Chem, Vol. 274, Issue 34, 24047-24053, August 20, 1999
Structure and Localization of the Mouse Prolyl Oligopeptidase
Gene*
Atsushi
Kimura
§,
Ikuya
Yoshida¶
,
Nobuo
Takagi¶
, and
Takayuki
Takahashi
**
From the
Division of Biological Sciences, Graduate
School of Science, the ¶ Research Center for Molecular
Genetics, and the
Division of Bioscience, Graduate School of
Environmental Earth Science, Hokkaido University,
Sapporo 060-0810, Japan
 |
ABSTRACT |
We have cloned and characterized the genomic
structure of the mouse gene for prolyl oligopeptidase that is mapped to
chromosome 10B2-B3. The gene is about 92 kilobases in size and contains
15 exons. All exon-intron junction sequences conform to the GT/AG rule.
Comparison with the presumed domain structures of the mouse prolyl
oligopeptidase indicates that the propeller domain of the enzyme is
encoded by exons 3-10, whereas the catalytic domain is encoded by
exons 1-3 and 10-15. The catalytic triad residues are encoded by two
exons (Ser554 on exon 13 and His680 and
Asp642 on exon 15). The 5'-flanking region of the mouse
prolyl oligopeptidase gene has structural features found in
housekeeping gene promoters, including a GC-rich segment and an absence
of TATA and CAAT boxes. A primer extension assay showed the presence of
multiple sites for the initiation of transcription. Transient
transfection analysis demonstrated that the 5'-flanking region of the
gene can direct efficient expression in COS1 cells. Deletion studies
revealed that the downstream 125-base pair sequence of the region is
required for promoter activity in the cells.
 |
INTRODUCTION |
Prolyl oligopeptidase, previously called prolyl endopeptidase or
post-proline cleaving enzyme, is a peptidase that cleaves the peptide
bonds at the carboxyl group of proline residues. Prolyl oligopeptidase
belongs to the serine peptidase family, but the enzyme is distinct from
trypsin and subtilisin in the order of the primary sequence of
catalytic triad residues (1). A very recent study by Fülöp
et al. (2) has established the unique three-dimensional
structure of porcine muscle prolyl oligopeptidase and may have solved
the perplexing problem of why the enzyme only hydrolyzes peptides
consisting of no more than 30 amino acid residues (3). Prolyl
oligopeptidase is found in various organisms, including mammals
(3-12), insects (13), plants (14), mushrooms (15, 16), and bacteria
(17-19). Such a wide distribution suggests the general importance of
this enzyme.
The biological function of prolyl oligopeptidase is not yet fully
understood, but its roles in various biological events have been
implicated. Because prolyl oligopeptidase is capable of rapidly degrading many peptide hormones and neuropeptides in vitro
(20, 21), the enzyme is presumed to be involved in their maturation and
degradation. In this connection, the enzyme has attracted special
attention from a pharmaceutical viewpoint in the light of the finding
that specific enzyme inhibitors reverse scopolamine-induced amnesia in
rats (22-25). In addition, its involvements in depression (26), blood
pressure through the metabolism of bradykinin and angiotensins I and II
(27), DNA synthesis (28, 29), the generation of amyloid
protein
(30-32), and cell proliferation and differentiation (13) have been
suggested. In order to define the roles of this enzyme, further studies
including a functional characterization of the gene are necessary.
Prolyl oligopeptidase has been cloned from several sources including
Flavobacterium meningosepticum (33), porcine brain (1),
human lymphocytes (34, 35), mouse brain (29), bovine brain (36), and
Sarcophaga peregrina (37). However, no gene structure of
prolyl oligopeptidase from eukaryotes is available to date. As an
initial approach to examining the mechanisms regulating prolyl
oligopeptidase gene expression in mammals, we have cloned and
characterized the mouse gene encoding prolyl oligopeptidase. In this
paper, we describe the structure and chromosome location of the mouse
prolyl oligopeptidase gene. In addition to the gene structure, we have
characterized the 5'-flanking region of the gene. The results suggest
that the gene has a "housekeeping promoter," characterized by the
lack of functional TATA and CAAT boxes as well as the presence of a
functional GC-rich promoter region.
 |
EXPERIMENTAL PROCEDURES |
Isolation and Characterization of the Mouse Prolyl Oligopeptidase
cDNA and Gene--
Poly(A) RNA was prepared from mouse
(C57Black/6, female, 8 weeks) brain using the guanidine
isothiocyanate-cesium chloride method (38) followed by
oligo(dT)-cellulose column chromatography. The adapter-ligated cDNA
was inserted into
gt10-EcoRI vector (Takara, Japan) and
packaged with GIGAPACK II GOLD (Stratagene, La Jolla, CA). About
3.4 × 105 clones were screened using the full-length
rat prolyl oligopeptidase cDNA previously isolated in our
laboratory (the sequence data available from the
DDBJ/EBI/GeneBankTM Data Bank with the accession number
AB012759) as a probe by plaque hybridization. Four positive plaques
were isolated and sequenced. The complete sequence of the 3'-end was
obtained by the 3'-rapid amplification of cDNA ends method (39)
using the 3'-Full RACE Core Set (Takara).
About 5 × 106 clones of the mouse genomic library
(C57Black/6, liver, female, 1 year, Stratagene) were screened with the
32P-labeled mouse prolyl oligopeptidase cDNA mixture of
the five total clones described above. Twelve positive plaques were
isolated, and digestion with several restriction enzymes revealed that
these plaques included four kinds of clones (P13, P23, P24, and P54). We determined the restriction enzyme maps of these four clones and
sequenced the restriction fragments containing exons using ABI
automatic sequencers, models 373 and 377 (Perkin-Elmer-Applied Biosystems, Foster City, CA). The gaps among these four clones were
filled by the long and accurate polymerase chain reaction (LA-PCR)1 method (40,
41).
Mouse (C57Black/6, female, 8 weeks) liver was homogenized and treated
with 20 µg/ml RNase A and then with 100 µg/ml proteinase K (Roche
Molecular Biochemicals). After repeated extraction with phenol, genomic
DNA was isolated by ethanol precipitation. The PCR was performed under
the following conditions: 1 min at 94 °C, 30 cycles of 10 s at
98 °C and 15 min at 66 °C, and 10 min at 72 °C. A 50-µl
portion of the reaction mixture contained 500 ng of genomic DNA, 1 × LA-PCR Buffer II (Mg2+-free), 2.5 mM
MgCl2, 0.4 mM dNTP mixture, 10 pmol paired
primers, and 2.5 units of LA Taq (Takara). The sense and
antisense primer pairs used were as follows: LA21 (filling the gap
between P13 and P23), 5'-GCATCCTGCCTGGTCTCAGCTTTAATTCTG-3' (identical
to 1471-1501 bp downstream of exon 2), and
5'-TAGGGGCAGCTTCACTATTGTGGAGCTTTC-3' (complementary to 10.7 kb upstream
of exon 3; LA78 (filling the gap between P23 and P24),
5'-AAAGCATGAACACCCCAGAGATCAGTTTCG-3' (identical to 223-253 bp
downstream of exon 6), and 5'-CATCTTGGTGATAGTCAACGAGGAGTACACAACC-3' (complementary to 185-219 upstream of exon 9); and LA105 (filling the
gap between P24 and P54), 5'-GGTTTACAATCACTGACGCTTAGGACCTCCTG-3' (identical to 3088-3120 bp downstream of exon 10), and
5'-GAGTGGCTGACTTGGCTGGATTCTTTTCTC-3' (complementary to 1074-1104 bp
upstream of exon 11). The PCR products were analyzed by restriction
enzyme mapping and sequencing.
Primer Extension--
1 µg of mouse brain poly(A) RNA or 50 µg of Escherichia coli transfer RNA was hybridized at
75 °C for 90 min in a total 20 µl of 10 mM Tris-HCl
(pH 8.3), 1 mM EDTA, and 0.25 M KCl with 2 pmol
of the oligonucleotide probes, PE1, 5'-CGTGCGAGCGGGCGAGCGG-3' (+306 to +288), PE2, 5'-ACAAGAGGGAGCGGAGTCGC-3' (+182 to +163), or PE3,
5'-TGAGCAACACTGTTCCTGAG-3' (
320 to
339), which had been endo-labeled with T4 polynucleotide kinase (Takara) and
[
-32P]ATP at 37 °C for 30 min. The reactions were
then allowed to cool for 90 min at room temperature. After adding 46 µl of 65 mM Tris-HCl (pH 8.3), 4.3 mM
MgCl2, 15 mM dithiothreitol, and 0.72 mM dNTP mixture, 200 units of Superscript II reverse
transcriptase (Life Technologies, Inc.) was introduced into the
reaction mixture, which was then incubated at 42 °C for 60 min. The
reactions were phenol-extracted, ethanol-precipitated, and
electrophoresed in a denaturing 6% polyacrylamide sequencing gel along
with a sequence ladder generated with the unlabeled primers using
[
-32P]dCTP and Sequenase version 2.0 (U.S. Biochemical
Corp.). The dried gel was visualized by autoradiography.
S1 Nuclease Mapping--
A 914-bp
EcoRI-BamHI fragment probe (nucleotides
541 to
+373) was 5'-endo-labeled with T4 polynucleotide kinase (Takara) and
[
-32P]ATP. The denatured probe (2 × 105 cpm) was hybridized to 50 µg of mouse brain total RNA
or E. coli transfer RNA in 80% formamide, 0.4 M
NaCl, 40 mM PIPES, and 1 mM EDTA at 62 °C
for 16 h. After hybridization, the mixture was digested with 800 units of S1 nuclease (Takara) at room temperature for 20 min. The
protected fragments were analyzed on a 5% polyacrylamide sequencing
gel. The 1-kb ladder (Life Technologies, Inc.) was endo-labeled and
used as a size marker.
Genomic Southern Blot Analysis--
Mouse genome DNA was
extracted as described above. 5 µg of the genomic DNA was completely
digested with EcoRI, HindIII, BamHI, and XbaI. The DNA was fractionated on a 0.7% agarose gel
and alkaline-transferred to a Nytran membrane (Schleicher & Schuell).
The blot was hybridized at 60 °C for 16 h in 6× SSPE, 5×
Denhardt's solution, 1% SDS, 10% dextran sulfate, and 100 µg/ml
denatured herring sperm DNA with a 32P-labeled 262-bp
HindIII-BamHI fragment of mouse prolyl
oligopeptidase cDNA, which is included in exon 15. The membrane was
washed at 60 °C in 0.1× SSC/0.1% SDS and exposed to Kodak Biomax film.
Chromosomal Localization of Mouse Prolyl Oligopeptidase by
Fluorescence in Situ Hybridization--
Metaphase spreads were
prepared from concanavalin A-stimulated splenocytes of normal male mice
after bromodeoxyuridine incorporation. R-banding was obtained by
exposure of the slides to ultraviolet light after staining with Hoechst
33258. A 200-ng sample of probe mixture (P13, P23, P54, LA78, and
LA105) was labeled with biotinylated-16-dUTP (Roche Molecular
Biochemicals) by nick translation. Prior to hybridization, the
chromosome slides were denatured in 70% formamide in 2× SSC at
75 °C and immediately chilled in 70% ethanol (0 °C) and
dehydrated. The probe was mixed with 2 µg of mouse Cot-1 DNA (Life
Technologies, Inc.) and denatured in formamide at 75 °C. The
hybridization was carried out at 42 °C for 48 h in 4× SSC, 4 mg/ml bovine serum albumin, and 20% dextran sulfate. The signal was
detected by sequential incubation with 3 µg/ml anti-biotin goat IgG
(Vectashield Vector laboratory, Burlingame, CA) and 40 µg/ml
fluorescein isothiocyanate-conjugated anti-goat IgG (American Qualex,
La Mirada, CA). Fluorescein isothiocyanate signals were further
amplified with 40 µg/ml Alexa 488 conjugated anti-fluorescein
isothiocyanate (Molecular Probes, Eugene, OR).
Plasmid Construction--
To construct promoter and reporter
fusion constructs, different portions of the 5'-flanking region
sequences were synthesized by PCR. The PCR was conducted in a total
50-µl volume of 100 ng of template plasmid clone containing the
5'-flanking region, 1× Ex Taq buffer, 0.2 mM
dNTP mixture, 10 pmol paired primers, and 2.5 units Ex Taq
(Takara). The reactions were performed under the following conditions:
1 min at 94 °C and 30 cycles of 30 s at 98 °C, 30 s at
60 °C, and 3 min at 72 °C. The downstream primers were
5'-CGCGGATCCTACACGTCGGGGTACTGGAA-3' (+406 to +387),
5'-CGCGGATCCGCGCCAAGCAGGAAGACGCT-3' (+249 to +230),
5'-CGCGGATCCACAAGAGGGAGCGGAGTCGC-3' (+182 to +163), and
5'-CGCGGATCCACCAGCCACTCTGTATATGG-3' (
62 to
81). The upstream primers were 5'-CCGGAATTCGAGGCCCATGGATAGAGAAG-3' (
422 to
403), 5'-CCGGAATTCAAGTTCTCTCACCTCGCTCC-3' (
256 to
237),
5'-CCGGAATTCGGCTGGTGGCAGGCAGGCGG-3' (
68 to
49), and
5'-CCGGAATTCTCCCTCTTGTCGCCGCTTGG-3' (+173 to +154). The PCR
products were sequenced and subcloned into pEGFP-1 vector
(CLONTECH, Palo Alto, CA) at
EcoRI-BamHI site. The whole promoter sequence
(
541 to +373) was subcloned from the plasmid clone containing the
5'-flanking region at EcoRI-BamHI site.
Cell Culture and Transfection--
The African green monkey
kidney SV40 transformed cell line (COS1, RCB0143) was purchased from
Riken Gene Bank (Tsukuba, Japan). The cells were cultured in
Dulbecco's modified Eagle's medium supplied with 10% fetal bovine
serum (Hyclone, Logan, UT), 0.3 mg/ml L-glutamine, 100 units/ml penicillin, and 0.1 mg/ml streptomycin (Life Technologies,
Inc.). When the cells in 75-cm2 flasks become confluent,
they were trypsinized with 0.25% trypsin/0.5 mM EDTA and
transferred into 10-cm dishes in the same medium at an initial
concentration of 1 × 106 cells/dish. The cells were
cultured for 24 h and transfected by a calcium phosphate
precipitation procedure (42) with 20 µg of plasmids and 20 µg of
pSV-
-Gal (Promega, Madison, WI). The transfected cells were further
cultured for 48 h. The harvested cells were washed twice with
phosphate-buffered saline, suspended in 2 ml/dish of phosphate-buffered
saline, and disrupted by the freeze-thawing method. After
centrifugation at 8000 × g for 10 min, the supernatant
was collected for use in the following assays. The green fluorescent
protein (GFP) activity was measured by spectrofluorometry using an
excitation wavelength of 488 nm and an emission wavelength of 507 nm.
The
-galactosidase assay was carried out as described by standard
protocols (43). The GFP activity was normalized by
-galactosidase activity.
 |
RESULTS AND DISCUSSION |
Cloning and Nucleotide Sequencing of the Mouse Prolyl
Oligopeptidase Gene--
We isolated four clones of P13 (13.0 kb), P23
(19.0 kb), P24 (11.0 kb), and P54 (20.9 kb) by screening the genomic
library. Because these four clones were found to neither encode the 7th and 8th exon nor overlap one another, the LA-PCR method was used to
fill the gaps between them. Three LA-PCR products, LA21 (7.0 kb), LA78
(21.9 kb), and LA105 (18.2 kb), were generated for the respective gaps.
Consequently, these overlapping seven clones spanned a length
approximately 99.1 kb long containing 91.9 kb of the complete prolyl
oligopeptidase gene (Fig. 1). The genome contained 15 exons ranging from 75 (2nd exon) to 767 bp (15th exon) in
size and 14 introns ranging from 1535 to 22.3 kb. All donor and
acceptor splicing sequences had consensus GT and AG dinucleotides,
respectively (Table I).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
Restriction maps and structural organization
of mouse prolyl oligopeptidase gene. The characteristic
-propeller (each domain indicated by an oval) and
peptidase domains (hatched boxes) are represented at the
top. The exon organization of the cDNA is shown below
the domain structure. A coding region is indicated by open
boxes, and noncoding regions are indicated by horizontal
lines. Exon numbers and the positions of the three active-site
residues (S, D, and H) are shown. At
the bottom, recombinant phage inserts (P13, P23, P24, and P54) and
LA-PCR products (LA21, LA78, and LA105) as well as the genomic
organization are indicated. The exons are represented on the upper side
with numbers, and the restriction maps are on the lower
side. Sites for XbaI (large bars),
HindIII (small bars), and EcoRI
(black circles) are indicated.
|
|
A very recent study by Fülöp et al. (2) has
established the tertiary structure of porcine muscle prolyl
oligopeptidase. The enzyme contains a peptidase domain with an
/
hydrolase fold, and the active site is covered by the central tunnel of
a unique
-propeller (2). Although the three-dimensional structure of the mouse prolyl oligopeptidase has not yet been determined, it should
be very similar to that of the porcine enzyme based on the remarkable
similarities in the amino acid sequences of the two enzymes (29).
Therefore, we have considered the relationship between the protein and
gene structures for the mouse prolyl oligopeptidase, assuming that the
mouse enzyme has basically the same catalytic and noncatalytic domain
organization (Fig. 1). The catalytic domain (or peptidase domain) is
composed of residues 1-72 and 428-710. This domain is encoded by
exons 1-3 for the amino-terminal portion and exons 10-15 for the
carboxyl-terminal portion. Exon 15, the longest exon encoding the
carboxyl-terminal 98 amino acid residues and the 3'-untranslated
regions, contains two catalytic triad residues (Asp642 and
His680) of the mouse prolyl oligopeptidase. The active site
serine residue (Ser554) is encoded by exon 13. On the other
hand, the noncatalytic domain corresponding to residues 73-427 is
encoded by exons 3-10. A structural feature of this domain is a 7-fold
repeat of four-stranded antiparallel
-sheets forming a
-propeller
domain with seven blades (2). These repeating units at the peptide
level are not encoded by individual exons. The mouse prolyl
oligopeptidase gene contains two large introns, intron 2 (19.1 kb) and
intron 10 (22.3 kb), resulting in a distribution of the exons in three
clusters (Fig. 1). In a general way, the first and last clusters of the
exons are responsible for the peptidase domain, whereas the middle one is responsible for the
-propeller domain. Such an exon-intron organization may indicate that prolyl oligopeptidase has evolved from
the insertion of the propeller domain into the NH2-terminal region of the peptidase domain.
Determination of the Transcription Initiation Site--
Ishino
et al. (29) have recently reported the nucleotide sequence
of mouse prolyl oligopeptidase cDNA. We also cloned the cDNA,
and our results confirmed their data, except that the sequence in the
5'-untranslated region was totally different. To explain this conflict
and to establish a basis for primer extension experiments and promoter
analysis of the gene, we conducted reverse transcriptase-PCR and LA-PCR
using different sets of primers. The results showed that the PCR
product was amplified only when using the synthesized primer sets based
on the sequences of our clone (data not shown). The real proof of the
accuracy of our cDNA sequence was its correspondence to the genomic sequence.
The precise location of the transcription initiation site of the mouse
prolyl oligopeptidase gene was determined by the primer extension
analysis. Using the primer PE1, one major band and two minor bands were
detected (Fig. 2a). From this
result, one of the minor sites was determined to be thymine (+139).
Because the major and the other minor bands were far upstream of the
PE1 primer site, we newly designed two primers, PE2 and PE3,
respectively, for further analysis. The results of experiments with
these primers indicated that the major start site is the thymine (+1)
(Fig. 2b) and the minor site is the guanine (
408) (Fig.
2c). To further confirm these findings, we conducted an S1
nuclease mapping experiment. As shown in Fig.
3, a major protected band was found in a
position corresponding to 235 bp, confirming that thymine (+139) is an important transcription initiation site. This result along with the
results of the primer extension analyses indicates that both thymines
(+1 and +139) are important initiation sites in the transcription of
the mouse prolyl oligopeptidase gene (Fig.
4).

View larger version (78K):
[in this window]
[in a new window]
|
Fig. 2.
Determination of 5'-ends of mouse prolyl
oligopeptidase transcripts by primer extension analysis. 1 µg of
mouse brain poly(A) RNA (lanes 1, 3, and
5) or 50 µg of E. coli transfer RNA
(lanes 2, 4, and 6) were annealed with
32P-labeled PE1 (lanes 1 and 2), PE2
(lanes 3 and 4), or PE3 (lanes 5 and
6) primers and extended with reverse transcriptase. The
extended products (indicated by arrows) were resolved by
sequencing gels in parallel with four sequencing reactions. The
positions of primers and the determined transcription initiation sites
are shown in Fig. 4.
|
|

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 3.
Identification of the major transcription
initiation site by S1 nuclease mapping. A 914-bp
EcoRI-BamHI fragment was 5'-endo-labeled and
hybridized to mouse brain total RNA (lane 3) or E. coli transfer RNA (lane 4). After S1 nuclease digestion, the
products were fractionated by electrophoresis and visualized by
autoradiography. The endo-labeled size marker (lane 1) and
the probe (lane 2) were also electrophoresed. The marker
sizes are shown on the left. The upper arrow
indicates the position of the probe, and the lower arrow
indicates a single protected band at 235 bp.
|
|

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 4.
DNA sequence of the 5'-flanking region of
mouse prolyl oligopeptidase gene. The positions are numbered from
the more upstream of the two main transcription initiation sites
identified, which is numbered +1. The transcription initiation sites
are indicated by bent arrows. The primers used in the primer
extension analysis (PE1, PE2, and PE3) are indicated by
horizontal arrows. Possible regulatory elements are
underlined or overlined. The BamHI
sites are shown in italic type, and the translation
initiation codon (ATG) is in bold type.
|
|
Although there is a TATAAT motif 915 bp upstream of ATG, this motif
could not work as a TATA box because the upstream minor transcription
initiation site is too distant from the motif. Consistent with these
observations is the presence of a consensus motif GCTCC(C/G) at four
positions in the sequence covering the nucleotides from
408 to the
ATG codon (Fig. 4). This motif is known as a multiple start site
element downstream (MED-1), which is detectable in many TATA-less
promoters with multiple start sites (44). This region is rich in G+C
and contains potential binding sites for several transcription factors
such as Sp1, Ap2, and E4TF.
Chromosome Localization of Mouse Prolyl Oligopeptidase
Gene--
With the Southern hybridization analysis, a single
hybridization-positive band was detected when mouse genomic DNA was
digested with four independent restriction enzymes (Fig.
5). Fluorescence in situ
hybridization analysis showed a single positive signal on chromosome
10B2-B3, and no other signal was detected (Fig. 6). This result is consistent with the
mapping of the human prolyl oligopeptidase gene to human chromosome
6q22 (45), because this region of mouse chromosome 10 shares a region
of synteny with human chromosome 6. These results indicate that the
mouse prolyl oligopeptidase is a single-copy gene located on chromosome
10B2-B3.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 5.
Genomic Southern blot analysis of mouse
prolyl oligopeptidase gene. 5 µg of mouse genomic DNA were used
in each digestion. The restriction enzymes selected are indicated. The
blot was hybridized with a 32P-labeled 262-bp
HindIII-BamHI fragment of mouse prolyl
oligopeptidase cDNA, which is included in exon 15. The membrane was
washed with a final stringency of 0.1 × SSC/0.1% SDS at 60 °C
before autoradiography. Molecular size markers are indicated to the
left.
|
|

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 6.
Chromosomal localization of mouse prolyl
oligopeptidase gene. A, metaphase chromosomes
hybridized with a mouse prolyl oligopeptidase genomic probe mixture.
Hybridization signals were detected at band B2-B3 on both chromosomes
10 (arrows). Of the 73 informative cells, the signals were
observed on all four chromatids in all 73 cells. B,
G-banding pattern of the same chromosome.
|
|
Characterization of the Promoter--
The mouse prolyl
oligopeptidase gene isolated in this study contained only 900 nucleotides in the 5'-flanking region. This size seemed somewhat too
short for promoter analysis. We tried to obtain the sequence further
upstream of the gene by screening an additional 2 × 106 genomic clones, but this attempt was not successful.
Therefore, we performed the promoter analysis of the gene with the
above region.
The mouse prolyl oligopeptidase gene contains neither a TATA box nor a
CAAT box in the region adjacent to the transcription start site (Fig.
4). Interestingly, the 5'-region immediately upstream of the ATG codon
is a GC-rich sequence (77.1% between
68 and +377). To examine
whether the 5'-flanking region, including the GC-rich sequence, of the
gene contained a functional promoter, we constructed a series of 5'- or
3'-deletion mutants linked to the GFP reporter gene (Fig.
7). The prolyl oligopeptidase activity was assayed for the extracts of cultured cells such as COS1, mouse B16
melanoma, and Lewis lung carcinoma cells. We observed that the COS1
cells exhibited the greatest activity (data not shown) and therefore
used this cell line for the promoter analysis. As shown in Fig. 7, the
5'-deletion from
541 to
422 appeared to cause a slight reduction
(26%) in promoter activity, but this reduction was not significant.
Further deletions from
422 to +173 led to no change in activity,
suggesting that the region from
541 to +173 was dispensable in the
cell. In contrast, transfection by the reporter plasmids with
3'-deletions had a remarkable effect on promoter activity. Deletion
from
62 to +373 retained only 7.3% of the promoter activity as
compared with that of the complete construct. This reduced activity was
not restored even by the 3'-deletion mutant lacking only the 125-bp
downstream region from +249 to +373. These results strongly suggest
that the region from +249 to +373 is required for high basal promoter
activity in COS1 cells.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 7.
Deletion analysis of the mouse prolyl
oligopeptidase promoter activity. The left panel
indicates schematic drawings of various fragments of the 5'-flanking
region subcloned into the upstream of the GFP reporter plasmid pEGFP-1
at EcoRI-BamHI sites. The numbers
indicate positions of the 5' or 3' terminus of the constructs. The
possible cis-element binding sites are shown at the top. The
reporter constructs are transfected into COS1 cells by the calcium
phosphate method. The measured GFP activity was shown in the
right panel. The data represent the averages ± S.E. of
at least four independent experiments. The GFP activity of the
promoter-less construct is significantly higher than that of some other
constructs, presumably because of the presence of an Ap2-binding motif
between EcoRI and BamHI of the pEGFP-1
multi-cloning site.
|
|
The 5'-flanking region of the mouse prolyl oligopeptidase gene is
characterized by the absence of a TATA motif and the presence of
several GC motifs. These structural features are often found in
promoters of the housekeeping genes (46, 47). The previous results of
Northern blot analyses attempting to identify prolyl oligopeptidase
mRNA in various pig (1) and human (34) tissues are compatible with
the idea that the prolyl oligopeptidase gene is a housekeeping gene.
However, further detailed investigation is necessary to determine in
what way this gene is a housekeeping gene. It is interesting to note
that the dipeptidyl peptidase IV gene, which belongs to the same prolyl
oligopeptidase family, also has a 5'-flanking region characteristic of
a housekeeping gene promoter (48).
Comparison with Dipeptidyl Peptidase IV--
Because the current
study provides for the first time the genomic structure of mammalian
prolyl oligopeptidase, it is worthwhile to compare this structure with
the gene structure of related peptidases. The only member of the prolyl
oligopeptidase family whose genomic structure has been analyzed so far
is mouse and human dipeptidyl peptidase IV (CD26) (49, 50). When the
amino acid sequences of mouse prolyl oligopeptidase (29) and dipeptidyl
peptidase IV (51) were compared, a moderate similarity was seen
throughout the sequences (identical residues were 15.1% in the
alignment taken with the Clustal W program (52); data not shown). A
comparable level of similarity (identical residues were 14.9%) was
observed between the amino acid sequences of the two enzymes even in
the COOH-terminal third of the alignment. The exon-intron organization of these mouse genes is quite different, however. Despite the comparable number of amino acid residues in the mouse enzymes (prolyl
oligopeptidase, 710 residues; dipeptidyl peptidase IV, 760 residues),
the number of exons in the two genes is different; the prolyl
oligopeptidase gene is composed of 15 exons, whereas the dipeptidyl
peptidase IV gene 26 exons. Because both genes encompass a similar
number of nucleotides (91.9 kb for the prolyl oligopeptidase gene and
more than 90 kb for the dipeptidyl peptidase IV gene), the average exon
of the prolyl oligopeptidase gene is approximately 1.6 times longer
than that of dipeptidyl peptidase IV gene. This greater length may
indicate that, evolutionally, new intron insertions have occurred more
frequently in the dipeptidyl peptidase IV gene than in the prolyl
oligopeptidase gene. Further comparative analysis revealed that none of
the exon-intron junctions of the two genes correspond with each other.
In addition, the catalytic triad residues of mouse prolyl
oligopeptidase are encoded by two exons (Ser554 on exon 13 and Asp642 and His680 on exon 15), whereas each
residue of mouse dipeptidyl peptidase IV is separately encoded by
different exons (Ser624 on exon 22, Asp702 on
exon 24, and His734 on exon 26) (49). Although it is clear
that prolyl oligopeptidase and dipeptidyl peptidase IV are related to
each other (53, 54), a comparison of their gene structures did not give
very much valuable information as to the evolution of these enzymes.
Conclusions--
In this study, we have cloned and characterized
the genomic structure of the mouse prolyl oligopeptidase gene. Our
present data clearly show that a single-copy gene in chromosome 10B2-B3 encodes mouse prolyl oligopeptidase. We have previously reported an
extracellular enzyme having properties indistinguishable from intracellular prolyl oligopeptidase in the porcine ovary (55). Subsequent studies have suggested that these intracellular and extracellular enzymes are the same products of a single gene (56). However, existing evidence points to the presence of other types of
prolyl oligopeptidase in mammalian tissues (57-60), although structural information on these enzymes has not been available to date.
We presume that some of the enzymes with enzymatic properties very
similar to those of prolyl oligopeptidase are perhaps the same gene
products but have undergone different posttranslational modification(s). An alternative processing event(s) involving internal
exons of the prolyl oligopeptidase gene could also produce enzymes with
modified properties. Another possibility is that a yet unidentified
gene(s) encodes a distinct enzyme(s) having prolyl oligopeptidase-like
enzyme activity. Further studies are definitely required to clarify the
relation between prolyl oligopeptidase and such enzymes. The current
data on the genomic structure of prolyl oligopeptidase should be
helpful in solving this problem.
Many studies have been carried out with prolyl oligopeptidase since its
discovery by Walter et al. (4) in 1971. Various physiological functions for the enzyme have been suggested to date, but
definitive evidence for its discrete biological role remains to be
provided. The current investigation should provide a foundation for
future studies of prolyl oligopeptidase, including loss or gain of gene
function studies.
 |
Note Added in Proof |
After this paper was accepted, Williams
et al. (61) have reported the structure of the
Dictyostelium prolyl oligopeptidase gene, and demonstrated
that loss of the gene caused an increased concentration of inositol
(1,4,5)-triphosphate, offering a novel mechanism that links the enzyme
activity to the intracellular signaling.
 |
FOOTNOTES |
*
This work was supported in part by a Grant-in-Aid for
Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AB022047, AB022048, AB022049, AB022050, AB022051, AB022052, and AB022053.
§
Supported by a Research Fellowship of the Japan Society for the
Promotion of Science.
**
To whom correspondence should be addressed: Div. of Biological
Sciences, Graduate School of Science, Hokkaido University, Sapporo
060-0810, Japan. Tel.: 81-11-706-2748; Fax: 81-11-706-4851; E-mail:
ttakaha@sci.hokudai.ac.jp.
 |
ABBREVIATIONS |
The abbreviations used are:
LA-PCR, long and
accurate polymerase chain reaction;
PIPES, piperazine-N,N'-bis[2-ethanesulfonic acid];
GFP, green fluorescent protein;
kb, kilobase(s);
bp, base pair(s).
 |
REFERENCES |
| 1.
|
Rennex, D.,
Hemmings, B. A.,
Hofsteenge, J.,
and Stone, S. R.
(1991)
Biochemistry
30,
2195-2203[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Fülöp, V.,
Böcskei, Z.,
and Polgár, L.
(1998)
Cell
94,
161-170[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Moriyama, A.,
Nakanishi, M.,
and Sasaki, M.
(1988)
J. Biochem. (Tokyo)
104,
112-117[Abstract/Free Full Text]
|
| 4.
|
Walter, R.,
Shlank, H.,
Glass, J. D.,
Schwartz, I. L.,
and Kerenyi, T. D.
(1971)
Science
173,
827-829[Abstract/Free Full Text]
|
| 5.
|
Koida, M.,
and Walter, R.
(1976)
J. Biol. Chem.
251,
7593-7599[Abstract/Free Full Text]
|
| 6.
|
Orlowski, M.,
Wilk, E.,
Pearce, S.,
and Wilsk, S.
(1979)
J. Neurochem.
33,
461-469[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Yoshimoto, T.,
Simmons, W. H.,
Kita, T.,
and Tsuru, D.
(1981)
J. Biochem. (Tokyo)
90,
325-334[Abstract/Free Full Text]
|
| 8.
|
Yoshimoto, T.,
Nishimura, T.,
Kita, A.,
and Tsuru, D.
(1983)
J. Biochem. (Tokyo)
94,
1179-1190[Abstract/Free Full Text]
|
| 9.
|
Mizutani, S.,
Sumi, S.,
Suzuki, O.,
Narita, O.,
and Tomoda, Y.
(1984)
Biochim. Biophys. Acta
786,
113-117[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Moriyama, A.,
and Sasaki, M.
(1983)
J. Biochem. (Tokyo)
94,
1387-1397[Abstract/Free Full Text]
|
| 11.
|
Kalwant, S.,
and Porter, A. G.
(1991)
Biochem. J.
276,
237-244
|
| 12.
|
Goossens, F.,
De Meester, I.,
Vanhoof, G.,
Hendriks, D.,
Vriend, G.,
and Scharpé, S.
(1995)
Eur. J. Biochem.
233,
432-441[Medline]
[Order article via Infotrieve]
|
| 13.
|
Ohtsuki, S.,
Homma, K.,
Kurata, S.,
Komano, H.,
and Natori, S.
(1994)
J. Biochem. (Tokyo)
115,
449-453[Abstract/Free Full Text]
|
| 14.
|
Yoshimoto, T.,
Sattar, A. K.,
Hirose, W.,
and Tsuru, D.
(1987)
Biochim. Biophys. Acta
916,
29-37
|
| 15.
|
Yoshimoto, T.,
Sattar, A. K.,
Hirose, W.,
and Tsuru, D.
(1988)
J. Biochem. (Tokyo)
104,
622-627[Abstract/Free Full Text]
|
| 16.
|
Sattar, A. K.,
Yamamoto, N.,
Yoshimoto, T.,
and Tsuru, D.
(1990)
J. Biochem. (Tokyo)
107,
256-261[Abstract/Free Full Text]
|
| 17.
|
Yoshimoto, T.,
Walter, R.,
and Tsuru, D.
(1980)
J. Biol. Chem.
255,
4786-4792[Free Full Text]
|
| 18.
|
Chevallier, S.,
Goeltz, P.,
Thibault, P.,
Banville, D.,
and Gagnon, J.
(1992)
J. Biol. Chem.
267,
8192-8199[Abstract/Free Full Text]
|
| 19.
|
Diefenthal, T.,
Dargatz, H.,
Witte, V.,
Reipen, G.,
and Svendsen, I.
(1993)
Appl. Microbiol. Biotechnol.
40,
90-97[Medline]
[Order article via Infotrieve]
|
| 20.
|
Wilk, S.
(1983)
Life Sci.
33,
2149-2157[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Mentlein, R.
(1988)
FEBS Lett.
234,
251-256[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Yoshimoto, T.,
Kado, K.,
Matsubara, F.,
Koriyama, N.,
Kaneto, H.,
and Tsuru, D.
(1987)
J. Pharmacobio-Dyn.
10,
730-735[Medline]
[Order article via Infotrieve]
|
| 23.
|
Atack, J. R.,
Suman-Chauhan, N.,
Dawson, G.,
and Kulagowski, J. J.
(1991)
Eur. J. Pharmacol.
205,
157-163[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Miura, N.,
Shibata, S.,
and Watanabe, S.
(1995)
Neurosci. Lett.
196,
128-130[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Portevin, B.,
Benoist, A.,
Rémond, G.,
Hervé, Y.,
Vincent, M.,
Lepagnol, J.,
and De Nanteuil, G.
(1996)
J. Med. Chem.
39,
2379-2391[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Maes, M.,
Goossens, F.,
Scharpé, S.,
Meltzer, H. Y.,
D'Hondt, P.,
and Cosyns, P.
(1994)
Biol. Psychiatry
35,
545-552[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Welches, W. R.,
Brosnihan, K. B.,
and Ferrario, C. M.
(1993)
Life Sci.
52,
1461-1480[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Ohtsuki, S.,
Homma, K.,
Kurata, S.,
and Natori, S.
(1997)
J. Biochem. (Tokyo)
121,
1176-1181[Abstract/Free Full Text]
|
| 29.
|
Ishino, T.,
Ohtsuki, S.,
Homma, K.,
and Natori, S.
(1998)
J. Biochem. (Tokyo)
123,
540-545[Abstract/Free Full Text]
|
| 30.
|
Ishiura, S.,
Tsukahara, T.,
Tabira, T.,
Shimizu, T.,
Arahata, K.,
and Sugita, H.
(1990)
FEBS Lett.
260,
131-134[CrossRef]
|
| 31.
|
Fukunari, A.,
Kato, A.,
Sakai, Y.,
Yoshimoto, T.,
Ishiura, S.,
Suzuki, K.,
and Nakajima, T.
(1994)
Neurosci. Lett.
176,
201-204[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Shinoda, M.,
Toide, K.,
Ohsawa, I.,
and Kohsaka, S.
(1997)
Biochem. Biophys. Res. Commun.
235,
641-645[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Yoshimoto, T.,
Kanatani, A.,
Shimoda, T.,
Inaoka, T.,
Kokubo, T.,
and Tsuru, D.
(1991)
J. Biochem. (Tokyo)
110,
873-878[Abstract/Free Full Text]
|
| 34.
|
Shirasawa, Y.,
Osawa, T.,
and Hirashima, A.
(1994)
J. Biochem. (Tokyo)
115,
724-729[Abstract/Free Full Text]
|
| 35.
|
Vanhoof, G.,
Goossens, F.,
Hendriks, L.,
De Meester, I.,
Hendriks, D.,
Vriend, G.,
Van Broeckhoven, C.,
and Scharpé, S.
(1994)
Gene (Amst.)
149,
363-366[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Yoshimoto, T.,
Miyazaki, K.,
Haraguchi, N.,
Kitazono, A.,
Kabashima, T.,
and Ito, K.
(1997)
Biol. Pharm. Bull.
20,
1047-1050[Medline]
[Order article via Infotrieve]
|
| 37.
|
Ohtsuki, S.,
Homma, K.,
Kurata, S.,
and Natori, S.
(1997)
Insect Biochem. Mol. Biol.
27,
337-343[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Chirgwin, J. M.,
Przybyla, A. E.,
MacDonald, R. J.,
and Rutter, W. J.
(1979)
Biochemistry
18,
5294-5299[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Frohman, M. A.,
Dush, M. K.,
and Martin, G. R.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
8998-9002[Abstract/Free Full Text]
|
| 40.
|
Barnes, W. M.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
2216-2220[Abstract/Free Full Text]
|
| 41.
|
Cheng, S.,
Fockler, C.,
Barnes, W. M.,
and Higuchi, R.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
5695-5699[Abstract/Free Full Text]
|
| 42.
|
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1992)
Current Protocols in Molecular Biology, Suppl. 14
, p. 9.1, Wiley Interscience, New York
|
| 43.
|
Rosenthal, N.
(1987)
Method Enzymol.
152,
704-720[Medline]
[Order article via Infotrieve]
|
| 44.
|
Ince, T. A.,
and Scotto, K. W.
(1995)
J. Biol. Chem.
270,
30249-30252[Abstract/Free Full Text]
|
| 45.
|
Goossens, F. J.,
Wauters, J. G.,
Vanhoof, G. C.,
Bossuyt, P. J.,
Schatteman, K. A.,
Loens, K.,
and Scharpé, S. L.
(1996)
Cytogenet. Cell Genet.
74,
99-101[Medline]
[Order article via Infotrieve]
|
| 46.
|
Dynan, W. S.
(1986)
Trends Genet.
2,
196-197[CrossRef]
|
| 47.
|
Bird, A. P.
(1986)
Nature
321,
209-213[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Böhm, S. K.,
Gum, J. R., Jr.,
Erickson, R. H.,
Hicks, J. W.,
and Kim, Y. S.
(1995)
Biochem. J.
311,
835-843
|
| 49.
|
Bernard, A-M.,
Mattei, M-G.,
Pierres, M.,
and Marguet, D.
(1994)
Biochemistry
33,
15204-15214[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Abbott, C. A.,
Baker, E.,
Sutherland, G. R.,
and McCaughan, G. W.
(1994)
Immunogenetics
40,
331-338[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Marguet, D.,
Bernard, A-M.,
Vivier, I.,
Darmoul, D.,
Naquet, P.,
and Pierres, M.
(1992)
J. Biol. Chem.
267,
2200-2208[Abstract/Free Full Text]
|
| 52.
|
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680[Abstract/Free Full Text]
|
| 53.
|
Barrett, A. J.,
and Rawlings, N. D.
(1992)
Biol. Chem. Hoppe-Seyler
373,
353-360[Medline]
[Order article via Infotrieve]
|
| 54.
|
Polgár, L.,
and Szabo, E.
(1992)
Biol. Chem. Hoppe-Seyler
373,
361-366[Medline]
[Order article via Infotrieve]
|
| 55.
|
Takahashi, T.,
Athauda, S. B. P.,
Mori, T.,
Kawashima, S.,
Matsushima, M.,
Ichinose, M.,
Miki, K.,
and Takahashi, K.
(1996)
Biomed. Res.
17,
435-442
|
| 56.
|
Kimura, A.,
Ohnishi, J.,
Okimura, H.,
Hamabata, T.,
and Takahashi, T.
(1998)
Mol. Reprod. Develop.
50,
121-127[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
O'Leary, R. M.,
and O'Connor, B.
(1995)
Eur. J. Biochem.
227,
277-283[Medline]
[Order article via Infotrieve]
|
| 58.
|
O'Leary, R. M.,
Gallagher, S. P.,
and O'Connor, B.
(1996)
Int. J. Biochem. Cell Biol.
28,
441-449[CrossRef][Medline]
[Order article via Infotrieve]
|
| 59.
|
Cunningham, D. F.,
and O'Connor, B.
(1997)
Eur. J. Biochem.
244,
900-903[Medline]
[Order article via Infotrieve]
|
| 60.
|
Matsubara, Y.,
Ono, T.,
Tsubuki, S.,
Irie, S.,
and Kawashima, S.
(1998)
Eur. J. Biochem.
252,
178-183[Medline]
[Order article via Infotrieve]
|
| 61.
|
Williams, R. S. B.,
Eames, M.,
Ryves, W. J.,
Viggars, J.,
and Harwood, A. J.
(1999)
EMBO J.
18,
2734-2745[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.